radioligand therapy – Page 4 – PROSTATE WARRIORS – The latest news about prostate cancer

Tag Archive for: radioligand therapy

Update: FC705 Signals a Leap Forward in Prostate Cancer Therapy, Outperforming Pluvicto

April 9, 2025/in Clinical Trial, Metastatic, Phase 2/by Max

New Radiotherapy ATNM-400 Targets Advanced Prostate Cancer

March 28, 2025/in Preclinical Research/by Max

Phase 1/2 trial: Novel rhPSMA Therapy Targets Advanced Prostate Cancer With Precision

March 14, 2025/in Clinical Trial, Metastatic, Phase 1, Phase 2/by Max

FutureChem Launches Phase 3 Trial for Novel PSMA-Targeted Radiopharmaceutical FC705

March 11, 2025/in Clinical Trial, Metastatic, Phase 3/by Max

SECuRE Trial Update: Promising Results in Metastatic Castration-Resistant Prostate Cancer

March 7, 2025/in Clinical Trial, Metastatic, Phase 2/by Max

The Phase 1 ACCEL Trial: Actinium-225-PSMA-62

February 28, 2025/in Clinical Trial, Metastatic, Phase 1, Phase 2/by Max

Pioneering Korean Trial Combines Radioligand Therapy and Immunotherapy for Advanced Prostate Cancer

February 7, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

Emerging Radiopharmaceuticals for Low PSMA-Expressing Prostate Cancer: 67Cu-SAR-bisFAP and 67Cu-SAR-bombesin

December 30, 2024/in Clinical Trial, Metastatic, Phase 1/by Max

Promising Results for 177Lu-PSMA-I&T in Prostate Cancer Treatment

November 15, 2024/in Clinical Trial, Metastatic, Phase 3/by Max

Positive Phase 1 Data Supports Phase 2 of 177Lu rhPSMA-10.1 for mCRPC

November 1, 2024/in Clinical Trial, Metastatic, Phase 1, Phase 2/by Max